176 related articles for article (PubMed ID: 38043102)
1. PLS3 Mutations in X-Linked Osteoporosis: Clinical and Genetic Features in Five New Families.
Costa A; Martins A; Machado C; Lundberg E; Nilsson O; Wang F; Costantini A; Tournis S; Höppner J; Grasemann C; Mäkitie O
Calcif Tissue Int; 2024 Feb; 114(2):157-170. PubMed ID: 38043102
[TBL] [Abstract][Full Text] [Related]
2. PLS3 sequencing in childhood-onset primary osteoporosis identifies two novel disease-causing variants.
Kämpe AJ; Costantini A; Mäkitie RE; Jäntti N; Valta H; Mäyränpää M; Kröger H; Pekkinen M; Taylan F; Jiao H; Mäkitie O
Osteoporos Int; 2017 Oct; 28(10):3023-3032. PubMed ID: 28748388
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel splicing mutation and genotype-phenotype correlations in rare PLS3-related childhood-onset osteoporosis.
Wu Z; Feng Z; Zhu X; Dai Z; Min K; Qiu Y; Yi L; Xu L; Zhu Z
Orphanet J Rare Dis; 2022 Jun; 17(1):247. PubMed ID: 35752817
[TBL] [Abstract][Full Text] [Related]
4. A novel large fragment deletion in PLS3 causes rare X-linked early-onset osteoporosis and response to zoledronic acid.
Lv F; Ma M; Liu W; Xu X; Song Y; Li L; Jiang Y; Wang O; Xia W; Xing X; Qiu Z; Li M
Osteoporos Int; 2017 Sep; 28(9):2691-2700. PubMed ID: 28620780
[TBL] [Abstract][Full Text] [Related]
5. PLS3 Deletions Lead to Severe Spinal Osteoporosis and Disturbed Bone Matrix Mineralization.
Kämpe AJ; Costantini A; Levy-Shraga Y; Zeitlin L; Roschger P; Taylan F; Lindstrand A; Paschalis EP; Gamsjaeger S; Raas-Rothschild A; Hövel M; Jiao H; Klaushofer K; Grasemann C; Mäkitie O
J Bone Miner Res; 2017 Dec; 32(12):2394-2404. PubMed ID: 28777485
[TBL] [Abstract][Full Text] [Related]
6. PLS3 Mutations in X-Linked Osteoporosis: Clinical and Bone Characteristics of Two Novel Mutations.
Kannu P; Mahjoub A; Babul-Hirji R; Carter MT; Harrington J
Horm Res Paediatr; 2017; 88(3-4):298-304. PubMed ID: 28605746
[TBL] [Abstract][Full Text] [Related]
7. X-Linked Osteogenesis Imperfecta Possibly Caused by a Novel Variant in
Brlek P; Antičević D; Molnar V; Matišić V; Robinson K; Aradhya S; Krpan D; Primorac D
Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946798
[TBL] [Abstract][Full Text] [Related]
8. Osteoporosis caused by mutations in PLS3: clinical and bone tissue characteristics.
Fahiminiya S; Majewski J; Al-Jallad H; Moffatt P; Mort J; Glorieux FH; Roschger P; Klaushofer K; Rauch F
J Bone Miner Res; 2014 Aug; 29(8):1805-14. PubMed ID: 24616189
[TBL] [Abstract][Full Text] [Related]
9. A novel frameshift deletion in PLS3 causing severe primary osteoporosis.
Costantini A; Krallis PΝ; Kämpe A; Karavitakis EM; Taylan F; Mäkitie O; Doulgeraki A
J Hum Genet; 2018 Aug; 63(8):923-926. PubMed ID: 29884797
[TBL] [Abstract][Full Text] [Related]
10. Teriparatide Treatment in Patients With WNT1 or PLS3 Mutation-Related Early-Onset Osteoporosis: A Pilot Study.
Välimäki VV; Mäkitie O; Pereira R; Laine C; Wesseling-Perry K; Määttä J; Kirjavainen M; Viljakainen H; Välimäki MJ
J Clin Endocrinol Metab; 2017 Feb; 102(2):535-544. PubMed ID: 27732335
[TBL] [Abstract][Full Text] [Related]
11. A novel splice mutation in PLS3 causes X-linked early onset low-turnover osteoporosis.
Laine CM; Wessman M; Toiviainen-Salo S; Kaunisto MA; Mäyränpää MK; Laine T; Pekkinen M; Kröger H; Välimäki VV; Välimäki MJ; Lehesjoki AE; Mäkitie O
J Bone Miner Res; 2015 Mar; 30(3):510-8. PubMed ID: 25209159
[TBL] [Abstract][Full Text] [Related]
12. PLS3 mutations in X-linked osteoporosis with fractures.
van Dijk FS; Zillikens MC; Micha D; Riessland M; Marcelis CL; de Die-Smulders CE; Milbradt J; Franken AA; Harsevoort AJ; Lichtenbelt KD; Pruijs HE; Rubio-Gozalbo ME; Zwertbroek R; Moutaouakil Y; Egthuijsen J; Hammerschmidt M; Bijman R; Semeins CM; Bakker AD; Everts V; Klein-Nulend J; Campos-Obando N; Hofman A; te Meerman GJ; Verkerk AJ; Uitterlinden AG; Maugeri A; Sistermans EA; Waisfisz Q; Meijers-Heijboer H; Wirth B; Simon ME; Pals G
N Engl J Med; 2013 Oct; 369(16):1529-36. PubMed ID: 24088043
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants in the PLS3 gene are associated with osteoporotic fractures in postmenopausal Chinese women.
Shao C; Wang YW; He JW; Fu WZ; Wang C; Zhang ZL
Acta Pharmacol Sin; 2019 Sep; 40(9):1212-1218. PubMed ID: 30837644
[TBL] [Abstract][Full Text] [Related]
14. Unique, Gender-Dependent Serum microRNA Profile in PLS3 Gene-Related Osteoporosis.
Mäkitie RE; Hackl M; Weigl M; Frischer A; Kämpe A; Costantini A; Grillari J; Mäkitie O
J Bone Miner Res; 2020 Oct; 35(10):1962-1973. PubMed ID: 32453450
[TBL] [Abstract][Full Text] [Related]
15. Novel PLS3 variants in X-linked osteoporosis: Exploring bone material properties.
Balasubramanian M; Fratzl-Zelman N; O'Sullivan R; Bull M; Fa Peel N; Pollitt RC; Jones R; Milne E; Smith K; Roschger P; Klaushofer K; Bishop NJ
Am J Med Genet A; 2018 Jul; 176(7):1578-1586. PubMed ID: 29736964
[TBL] [Abstract][Full Text] [Related]
16. Atypical femur fracture in an adolescent boy treated with bisphosphonates for X-linked osteoporosis based on PLS3 mutation.
van de Laarschot DM; Zillikens MC
Bone; 2016 Oct; 91():148-51. PubMed ID: 27477003
[TBL] [Abstract][Full Text] [Related]
17.
Mäkitie RE; Niinimäki T; Suo-Palosaari M; Kämpe A; Costantini A; Toiviainen-Salo S; Niinimäki J; Mäkitie O
Front Endocrinol (Lausanne); 2020; 11():393. PubMed ID: 32655496
[No Abstract] [Full Text] [Related]
18. Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis.
van Meurs JB; Trikalinos TA; Ralston SH; Balcells S; Brandi ML; Brixen K; Kiel DP; Langdahl BL; Lips P; Ljunggren O; Lorenc R; Obermayer-Pietsch B; Ohlsson C; Pettersson U; Reid DM; Rousseau F; Scollen S; Van Hul W; Agueda L; Akesson K; Benevolenskaya LI; Ferrari SL; Hallmans G; Hofman A; Husted LB; Kruk M; Kaptoge S; Karasik D; Karlsson MK; Lorentzon M; Masi L; McGuigan FE; Mellström D; Mosekilde L; Nogues X; Pols HA; Reeve J; Renner W; Rivadeneira F; van Schoor NM; Weber K; Ioannidis JP; Uitterlinden AG;
JAMA; 2008 Mar; 299(11):1277-90. PubMed ID: 18349089
[TBL] [Abstract][Full Text] [Related]
19. Treatment for osteoporosis in people with ß-thalassaemia.
Bhardwaj A; Swe KM; Sinha NK; Osunkwo I
Cochrane Database Syst Rev; 2016 Mar; 3():CD010429. PubMed ID: 26964506
[TBL] [Abstract][Full Text] [Related]
20. Impaired bone strength and bone microstructure in a novel early-onset osteoporotic rat model with a clinically relevant
Hu J; Zhou B; Lin X; Zhang Q; Guan F; Sun L; Liu J; Wang O; Jiang Y; Xia WB; Xing X; Li M
Elife; 2023 Apr; 12():. PubMed ID: 37083757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]